Advertisement
JOURNAL ARTICLES
VEGF is required for growth and survival in neonatal mice
H.P. Gerber, K.J. Hillan, A.M. Ryan, J. Kowalski, G.A. Keller, L. Rangell, B.D. Wright, F. Radtke, M. Aguet, N. Ferrara
Development 1999 126: 1149-1159;

Summary

We employed two independent approaches to inactivate the angiogenic protein VEGF in newborn mice: inducible, Cre-loxP- mediated gene targeting, or administration of mFlt(1–3)-IgG, a soluble VEGF receptor chimeric protein. Partial inhibition of VEGF achieved by inducible gene targeting resulted in increased mortality, stunted body growth and impaired organ development, most notably of the liver. Administration of mFlt(1–3)-IgG, which achieves a higher degree of VEGF inhibition, resulted in nearly complete growth arrest and lethality. Ultrastructural analysis documented alterations in endothelial and other cell types. Histological and biochemical changes consistent with liver and renal failure were observed. Endothelial cells isolated from the liver of mFlt(1–3)-IgG-treated neonates demonstrated an increased apoptotic index, indicating that VEGF is required not only for proliferation but also for survival of endothelial cells. However, such treatment resulted in less significant alterations as the animal matured, and the dependence on VEGF was eventually lost some time after the fourth postnatal week. Administration of mFlt(1–3)-IgG to juvenile mice failed to induce apoptosis in liver endothelial cells. Thus, VEGF is essential for growth and survival in early postnatal life. However, in the fully developed animal, VEGF is likely to be involved primarily in active angiogenesis processes such as corpus luteum development.

Reference

    1. Alon T.,
    2. Hemo I.,
    3. Itin A.,
    4. Pe'er J.,
    5. Stone J.,
    6. Keshet E.
    (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med 1, 1024–028
    OpenUrlCrossRefPubMedWeb of Science
    1. Augustin H. G.,
    2. Braun K.,
    3. Telemenakis I.,
    4. Modlich U.,
    5. Kuhn W.
    (1995) Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am. J. Pathol 147, 339–351
    OpenUrlPubMedWeb of Science
    1. Baker J.,
    2. Liu J. P.,
    3. Robertson E. J.,
    4. Efstratiadis A.
    (1993) Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75, 73–82
    OpenUrlCrossRefPubMedWeb of Science
    1. Benjamin L.,
    2. Hemo I.,
    3. Keshet E.
    (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125, 1591–1598
    OpenUrlAbstract
    1. Benjamin L. E.,
    2. Keshet E.
    (1997) Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc. Natl. Acad. Sci. USA 94, 8761–8766
    OpenUrlAbstract/FREE Full Text
    1. Borgström P.,
    2. Bourdon M. A.,
    3. Hillan K. J.,
    4. Sriramarao P.,
    5. Ferrara N.
    (1998) Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 35, 1–10
    OpenUrlCrossRefPubMedWeb of Science
    1. Brooks P. C.,
    2. Montgomery A. M.,
    3. Rosenfeld M.,
    4. Reisfeld R. A.,
    5. Hu T.,
    6. Klier G.,
    7. Cheresh D. A.
    (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164
    OpenUrlCrossRefPubMedWeb of Science
    1. Broxmwyer H. E.,
    2. Cooper S.,
    3. Li Z. H.,
    4. Song H. Y.,
    5. Kwon B. S.,
    6. Warren R. E.,
    7. Donner D. B.
    (1995) Myeloid progenitor cell regulatory effects of vascular endothelial growth factor. Int. J. Hematol 62, 203–215
    OpenUrlCrossRefPubMedWeb of Science
    1. Carmeliet P.,
    2. Collen D.
    (1998) Vascular development and disorders: Molecular analysis and pathogenic insights. Kidney Internat 53, 1519–1549
    OpenUrlCrossRefPubMedWeb of Science
    1. Carmeliet P.,
    2. Ferreira V.,
    3. Breier G.,
    4. Pollefeyt S.,
    5. Kieckens L.,
    6. Gertsenstein M.,
    7. Fahrig M.,
    8. Vandenhoeck A.,
    9. Harpal K.,
    10. Eberhardt C.,
    11. Declercq C.,
    12. Pawling J.,
    13. Moons L.,
    14. Collen D.,
    15. Risau W.,
    16. Nagy A.
    (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439
    OpenUrlCrossRefPubMedWeb of Science
    1. Clapp C.,
    2. Martial J. A.,
    3. Guzman R. C.,
    4. Rentier-Delrue F.,
    5. Weiner R. I.
    (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133, 1292–1299
    OpenUrlCrossRefPubMedWeb of Science
    1. Davis-Smyth T.,
    2. Chen H.,
    3. Park J.,
    4. Presta L. G.,
    5. Ferrara N.
    (1996) The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J 15, 4919–4927
    OpenUrlPubMedWeb of Science
    1. Esser S.,
    2. Wolburg K.,
    3. Wolburg H.,
    4. Breier G.,
    5. Kurzchalia T.,
    6. Risau W.
    (1998) Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol 140, 947–959
    OpenUrlAbstract/FREE Full Text
    1. Ferrara N.,
    2. Carver Moore K.,
    3. Chen H.,
    4. Dowd M.,
    5. Lu L.,
    6. O'Shea K. S.,
    7. Powell Braxton L.,
    8. Hillan K. J.,
    9. Moore M. W.
    (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439–442
    OpenUrlCrossRefPubMedWeb of Science
    1. Ferrara N.,
    2. Chen H.,
    3. Davis-Smyth T.,
    4. Gerber H.-P.,
    5. Nguyen T.-N.,
    6. Peers D.,
    7. Chisholm V.,
    8. Hillan K. J.,
    9. Schwall R. H.
    (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med 4, 336–340
    OpenUrlCrossRefPubMedWeb of Science
    1. Ferrara N.,
    2. Davis-Smyth T.
    (1997) The biology of vascular endothelial growth factor. Endocr. Rev 18, 4–25
    OpenUrlCrossRefPubMedWeb of Science
    1. Fong G. H.,
    2. Rossant J.,
    3. Gertsenstein M.,
    4. Breitman M. L.
    (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66–70
    OpenUrlCrossRefPubMedWeb of Science
    1. Gerber H. P.,
    2. Dixit V.,
    3. Ferrara N.
    (1998) Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem 273, 13313–13316
    OpenUrlAbstract/FREE Full Text
    1. Gerber H. P.,
    2. McMurtrey A.,
    3. Kowalski J.,
    4. Yan M.,
    5. Keyt B.,
    6. Dixit V.,
    7. Ferrara N.
    (1998) VEGF regulates endothelial cell survival by the PI3-kinase/Akt Signal transduction pathway. Requirement for Flk-1/KDR activation. J. Biol. Chem 273, 30336–30345
    OpenUrlAbstract/FREE Full Text
    1. Gibson U. E. M.,
    2. Heid C. A.,
    3. Williams P. M.
    (1996) A novel method for real time quantitative RT-PCR. Genome Res 6, 995–1001
    OpenUrlAbstract/FREE Full Text
    1. Good D.,
    2. Polverini P.,
    3. Rastinejad F.,
    4. Beau M.,
    5. Lemons R.,
    6. Frazier W.,
    7. Bouck N.
    (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624–6628
    OpenUrlAbstract/FREE Full Text
    1. Gu H.,
    2. Marth J. D.,
    3. Orban P. C.,
    4. Mossmann H.,
    5. Rajewsky K.
    (1994) Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265, 103–106
    OpenUrlAbstract/FREE Full Text
    1. Heid C. A.,
    2. Stevens J.,
    3. Livak K. J.,
    4. Williams P. M.
    (1996) Real time quantitative PCR. Genome Res 6, 986–994
    OpenUrlAbstract/FREE Full Text
    1. Hiratsuka S.,
    2. Minowa O.,
    3. Kuno J.,
    4. Noda T.,
    5. Shibuya M.
    (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95, 9349–9354
    OpenUrlAbstract/FREE Full Text
    1. Hirschi K. K.,
    2. D'Amore P. A.
    (1996) Pericytes in the microvasculature. Cardiovasc. Res 32, 687–698
    OpenUrlCrossRefPubMedWeb of Science
    1. Huang S.,
    2. Hendriks W.,
    3. Althage A.,
    4. Hemmi S.,
    5. Bluethmann H.,
    6. Kamijo R.,
    7. Vilcek J.,
    8. Zinkernagel R. M.,
    9. Aguet M.
    (1993) Immune response in mice that lack the interferon-gamma receptor. Science 259, 1742–1745
    OpenUrlAbstract/FREE Full Text
    1. Jelkmann W.
    (1992) Erythropoietin: structure, control of production and function. Physiol. Rev 72, 449–489
    OpenUrlFREE Full Text
    1. Katoh O.,
    2. Tauchi H.,
    3. Kawaishi K.,
    4. Kimura A.,
    5. Sarow Y.
    (1995) Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopietic cells and inhibitory effects of VEGF on apoptotic cell death caused by ionizing radiations. Cancer Res 55, 5687–5692
    OpenUrlAbstract/FREE Full Text
    1. Keyt B. A.,
    2. Nguyen H. V.,
    3. Berleau L. T.,
    4. Duarte C. M.,
    5. Park J.,
    6. Chen H.,
    7. Ferrara N.
    (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem 271, 5638–5646
    OpenUrlAbstract/FREE Full Text
    1. Kitamoto Y.,
    2. Tokunaga H.,
    3. Tomita K.
    (1997) Vascular endothelial growth factor is an essential molecule for mouse kidney development. J. Clin. Invest 99, 2351–2357
    OpenUrlCrossRefPubMedWeb of Science
    1. Kuhn R.,
    2. Schwenk F.,
    3. Aguet M.,
    4. Rajewsky K.
    (1995) Inducible gene targeting in mice. Science 269, 1427–1429
    OpenUrlAbstract/FREE Full Text
    1. Monacci W. T.,
    2. Merrill M. J.,
    3. Oldfield E. H.
    (1993) Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. Am. J. Physiol 264, 995–1002
    OpenUrl
    1. Nehls V.,
    2. Drenckhahn D.
    (1993) The versatility of microvascular pericytes: From mesenchyme to smooth muscle?. Histochemistry 99, 1–12
    OpenUrlCrossRefPubMedWeb of Science
    1. O'Reilly M. O.,
    2. Boehm T.,
    3. Shing Y.,
    4. Fukai N.,
    5. Vasios G.,
    6. Lane W. S.,
    7. Flynn E.,
    8. Birkhead J. R.,
    9. Olsen B. R.,
    10. Folkman J.
    (1997) Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277–285
    OpenUrlCrossRefPubMedWeb of Science
    1. O'Reilly M. S.,
    2. Holmgren L.,
    3. Shing Y.,
    4. Chen C.,
    5. Rosenthal R. A.,
    6. Moses M.,
    7. Lane W. S.,
    8. Cao Y.,
    9. Sage E. H.,
    10. Folkman J.
    (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328
    OpenUrlCrossRefPubMedWeb of Science
    1. Patan S.,
    2. Haenni B.,
    3. Burri P. H.
    (1997) Implementation of intussusceptive microvascular growth in the chicken chorioallantoic membrane (CAM). Microvasc. Res 53, 33–52
    OpenUrlCrossRefPubMed
    1. Presta L. G.,
    2. Chen H.,
    3. O'Connor S. J.,
    4. Chisholm V.,
    5. Meng Y. G.,
    6. Krummen L.,
    7. Winkler M.,
    8. Ferrara N.
    (1997) Humanization of an anti-VEGF monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res 57, 4593–4599
    OpenUrlAbstract/FREE Full Text
    1. Quinn T. P.,
    2. Peters K. G.,
    3. De Vries C.,
    4. Ferrara N.,
    5. Williams L. T.
    (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533–7637
    OpenUrlAbstract/FREE Full Text
    1. Risau W.
    (1995) Differentiation of endothelium. FASEB J 9, 926–933
    OpenUrlAbstract
    1. Risau W.
    (1997) Mechanisms of angiogenesis. Nature 386, 671–674
    OpenUrlCrossRefPubMedWeb of Science
    1. Roberts W. G.,
    2. Palade G. E.
    (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci 108, 2369–2379
    OpenUrlAbstract/FREE Full Text
    1. Sage E. H.,
    2. Bassuk J. A.,
    3. Vost J. C.,
    4. Folkman M. J.,
    5. Lane T. F.
    (1995) Inhibition of endothelial cell proliferation by SPARC is mediatedthrough a Ca (2+)-binding EF-hand sequence. J. Cell Biochem 57, 127–140
    OpenUrlCrossRefPubMedWeb of Science
    1. Shalaby F.,
    2. Rossant J.,
    3. Yamaguchi T. P.,
    4. Gertsenstein M.,
    5. Wu X. F.,
    6. Breitman M. L.,
    7. Schuh A. C.
    (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62–66
    OpenUrlCrossRefPubMedWeb of Science
    1. Shalaby F.,
    2. Ho J.,
    3. Stanford W. L.,
    4. Fisher K. D.,
    5. Schuh A. C.,
    6. Schwartz L.,
    7. Bernstein A.,
    8. Rossant J.
    (1997) A requirement for flk-1 in primitive and definitive hematopoiesis. Cell 89, 981–990
    OpenUrlCrossRefPubMedWeb of Science
    1. Vecchi A.,
    2. Garlanda C.,
    3. Lampugnani M. G.,
    4. Resnati C.,
    5. Matteucci C.,
    6. Stoppacciaro A.,
    7. Schnurch H.,
    8. Risau W.,
    9. Ruco L.,
    10. Mantovani A.,
    11. Dejana E.
    (1994) Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol 63, 247–254
    OpenUrlPubMedWeb of Science
    1. Yuan F.,
    2. Chen Y.,
    3. Dellian M.,
    4. Safabakhsh N.,
    5. Ferrara N.,
    6. Jain R. K.
    (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA 93, 14765–14770
    OpenUrlAbstract/FREE Full Text
Back to top

 Download PDF

Email
JOURNAL ARTICLES
VEGF is required for growth and survival in neonatal mice
H.P. Gerber, K.J. Hillan, A.M. Ryan, J. Kowalski, G.A. Keller, L. Rangell, B.D. Wright, F. Radtke, M. Aguet, N. Ferrara
Development 1999 126: 1149-1159;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Alerts

Article navigation

Other journals from The Company of Biologists

Advertisement

Kathryn Virginia Anderson (1952-2020)

Developmental geneticist Kathryn Anderson passed away at home on 30 November 2020. Tamara Caspary, a former postdoc and friend, remembers Kathryn and her remarkable contribution to developmental biology.

Zooming into 2021

In a new Editorial, Editor-in-Chief James Briscoe and Executive Editor Katherine Brown reflect on the triumphs and tribulations of the last 12 months, and look towards a hopefully calmer and more predictable year.

Read & Publish participation extends worldwide

Over 60 institutions in 12 countries are now participating in our Read & Publish initiative. Here, James Briscoe explains what this means for his institution, The Francis Crick Institute. Find out more and view our full list of participating institutions.

Upcoming special issues

Imaging Development, Stem Cells and Regeneration
Submission deadline: 30 March 2021
Publication: mid-2021

The Immune System in Development and Regeneration
Guest editors: Florent Ginhoux and Paul Martin
Submission deadline: 1 September 2021
Publication: Spring 2022

Both special issues welcome Review articles as well as Research articles, and will be widely promoted online and at key global conferences.

Development presents...

Our successful webinar series continues into 2021, with early-career researchers presenting their papers and a chance to virtually network with the developmental biology community afterwards. Sign up to join our next session:

10 February
Time: 13:00 (GMT)
Chaired by: preLights